Evidence map›Paper›PMID 22817912›Full record

ReviewTrends in immunology2012

Defining the subcellular sites of innate immune signal transduction.

Jonathan C Kagan

Abstract readReview
In one paragraph

Review in Trends in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Drugging endosomal flux.Nature chemical biology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Threonine phosphorylation of STAT1 restricts interferon signaling and promotes innate inflammatory responses.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Inhibitory pattern recognition receptors.The Journal of experimental medicine · 2022
    Review
  11. Polyvalent design in the cGAS-STING pathway.Seminars in immunology · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jonathan C KaganHarvard Medical School and Division of Gastroenterology, Children's Hospital Boston, Boston, MA 02115, USA. jonathan.kagan@childrens.harvard.edu

Funding

Initiation and Regulation of Antiviral Innate ImmunityR01AI093589 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2011 to 2020
$4.4M
Cellular and molecular aspects of Toll-like receptor signal transduction.R00AI072955 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI KAGAN, JONATHAN C · 2008 to 2009
$498k
NIAID NIH HHS AI072955NIAID NIH HHS AI093589NIAID NIH HHS R00 AI072955NIAID NIH HHS R01 AI093589
6 · The paper itself

Abstract

Innate immune activation by microbial detection receptors is a complex process involving at least 100 proteins and multiple signaling pathways. Although there continues to be a need to identify additional regulators of host-microbe interactions, a larger conceptual challenge is our lack of understanding of how the known regulators interact in space and time. This review offers a framework to explain the long appreciated (but poorly understood) observation that innate immune signaling pathways are activated from multiple organelles. Using the Toll-like receptors (TLRs) and the retinoic acid-inducible gene 1 protein (RIG-I)-like receptors (RLRs) as examples, I propose that the receptors do not necessarily define the sites of signaling. Rather, a structurally unrelated class of proteins called 'sorting adaptors' functions in this capacity.

Indexed as

Immunity, InnateSignal TransductionAnimalsHumansIntracellular SpaceLigandsReceptors, Antigen, T-CellLigandsReceptors, Antigen, T-Cell

Identifiers

PMID22817912
PMCPMC3427413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.